International Validation of the SULF-FAST Risk-Stratification Tool for Sulfonamide Antibiotic Allergy.

Saved in:
Bibliographic Details
Title: International Validation of the SULF-FAST Risk-Stratification Tool for Sulfonamide Antibiotic Allergy.
Authors: Stehlin F; Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Center (MUHC), McGill University, Montreal, Quebec, Canada.; Division of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, Lausanne, Switzerland.; The Research Institute of the McGill University Health Centre, McGill University, McGill University Health Centre (MUHC), Montreal, Quebec, Canada., Vogrin S; Center for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia., Mitri E; Center for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.; Department of Infectious Diseases, at the Peter Doherty Institute for Infection and Immunity, Melbourne Medical School, University of Melbourne, Victoria, Australia., Isabwe GAC; Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Center (MUHC), McGill University, Montreal, Quebec, Canada.; The Research Institute of the McGill University Health Centre, McGill University, McGill University Health Centre (MUHC), Montreal, Quebec, Canada., Trubiano JA; Center for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.; Department of Infectious Diseases, at the Peter Doherty Institute for Infection and Immunity, Melbourne Medical School, University of Melbourne, Victoria, Australia., Copaescu AM; Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Center (MUHC), McGill University, Montreal, Quebec, Canada.; The Research Institute of the McGill University Health Centre, McGill University, McGill University Health Centre (MUHC), Montreal, Quebec, Canada.; Center for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.; Department of Infectious Diseases, at the Peter Doherty Institute for Infection and Immunity, Melbourne Medical School, University of Melbourne, Victoria, Australia.
Source: JAMA network open [JAMA Netw Open] 2025 Jul 01; Vol. 8 (7), pp. e2519113. Date of Electronic Publication: 2025 Jul 01.
Publication Type: Journal Article
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40622717
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: International Validation of the SULF-FAST Risk-Stratification Tool for Sulfonamide Antibiotic Allergy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Stehlin+F%22">Stehlin F</searchLink>; Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Center (MUHC), McGill University, Montreal, Quebec, Canada.; Division of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, Lausanne, Switzerland.; The Research Institute of the McGill University Health Centre, McGill University, McGill University Health Centre (MUHC), Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Vogrin+S%22">Vogrin S</searchLink>; Center for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Mitri+E%22">Mitri E</searchLink>; Center for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.; Department of Infectious Diseases, at the Peter Doherty Institute for Infection and Immunity, Melbourne Medical School, University of Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Isabwe+GAC%22">Isabwe GAC</searchLink>; Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Center (MUHC), McGill University, Montreal, Quebec, Canada.; The Research Institute of the McGill University Health Centre, McGill University, McGill University Health Centre (MUHC), Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Trubiano+JA%22">Trubiano JA</searchLink>; Center for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.; Department of Infectious Diseases, at the Peter Doherty Institute for Infection and Immunity, Melbourne Medical School, University of Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Copaescu+AM%22">Copaescu AM</searchLink>; Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Center (MUHC), McGill University, Montreal, Quebec, Canada.; The Research Institute of the McGill University Health Centre, McGill University, McGill University Health Centre (MUHC), Montreal, Quebec, Canada.; Center for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.; Department of Infectious Diseases, at the Peter Doherty Institute for Infection and Immunity, Melbourne Medical School, University of Melbourne, Victoria, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101729235%22">JAMA network open</searchLink> [JAMA Netw Open] 2025 Jul 01; Vol. 8 (7), pp. e2519113. <i>Date of Electronic Publication: </i>2025 Jul 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101729235 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2574-3805 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225743805%22">25743805 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Netw Open <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40622717
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamanetworkopen.2025.19113
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e2519113
    Titles:
      – TitleFull: International Validation of the SULF-FAST Risk-Stratification Tool for Sulfonamide Antibiotic Allergy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Stehlin F
      – PersonEntity:
          Name:
            NameFull: Vogrin S
      – PersonEntity:
          Name:
            NameFull: Mitri E
      – PersonEntity:
          Name:
            NameFull: Isabwe GAC
      – PersonEntity:
          Name:
            NameFull: Trubiano JA
      – PersonEntity:
          Name:
            NameFull: Copaescu AM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2025 Jul 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2574-3805
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: JAMA network open
              Type: main
ResultId 1